| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7649b77c98cdca3647fe825abf0b4402 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2006-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621bc11f8b87866fc1394cbc07c3ed5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831bc9ece302fb23023e6d233df21d93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e35b46f72764b579f712f5e00f4ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07bb4c6d1c5560ea59021a4152b64e0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7fd84853a56adfb3fb2d19774b4c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd560f6076d6d1beee474a31edb04a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d559fa3683abea12f97dc212ea5ddd39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6b7fbfb6c0fd9c3383c640a58c0014 |
| publicationDate |
2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1863476-A1 |
| titleOfInvention |
The combination of anticholinergics and leukotriene receptor antagonists for the treatment of repiratory diseases |
| abstract |
The present invention relates to a combination comprising topical (inhaled) anticholinergics and inhaled or oral leukotriene (LT) receptor antagonists (BLT- and CysLT-receptor antagonists) for the treatment of respiratory diseases including allergic rhinitis, bronchial asthma and chronic obstructive pulmonary diseases (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®. |
| priorityDate |
2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |